These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 11386265)

  • 1. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS.
    Gao X; Nelson GW; Karacki P; Martin MP; Phair J; Kaslow R; Goedert JJ; Buchbinder S; Hoots K; Vlahov D; O'Brien SJ; Carrington M
    N Engl J Med; 2001 May; 344(22):1668-75. PubMed ID: 11386265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.
    Carrington M; Nelson GW; Martin MP; Kissner T; Vlahov D; Goedert JJ; Kaslow R; Buchbinder S; Hoots K; O'Brien SJ
    Science; 1999 Mar; 283(5408):1748-52. PubMed ID: 10073943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.
    Martin MP; Gao X; Lee JH; Nelson GW; Detels R; Goedert JJ; Buchbinder S; Hoots K; Vlahov D; Trowsdale J; Wilson M; O'Brien SJ; Carrington M
    Nat Genet; 2002 Aug; 31(4):429-34. PubMed ID: 12134147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular insights into the HLA-B35 molecules' classification associated with HIV control.
    Lobos CA; Chatzileontiadou DS; Sok B; Almedia CA; Halim H; D'Orsogna L; Gras S
    Immunol Cell Biol; 2024 Jan; 102(1):34-45. PubMed ID: 37811811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between MHC class I and susceptibility to HIV-2 disease progression.
    Diouf K; Sarr AD; Eisen G; Popper S; Mboup S; Kanki P
    J Hum Virol; 2002; 5(1):1-7. PubMed ID: 12352262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8+ T cells recognize vestigial CTL epitopes.
    Willberg CB; Garrison KE; Jones RB; Meiklejohn DA; Spotts G; Liegler TJ; Ostrowski MA; Karlsson AC; Hecht FM; Nixon DF
    PLoS One; 2010 Apr; 5(4):e10249. PubMed ID: 20422053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major histocompatibility complex genotype is associated with disease progression and virus load levels in a cohort of human immunodeficiency virus type 1-infected Caucasians and African Americans.
    Mann DL; Garner RP; Dayhoff DE; Cao K; Fernández-Viña MA; Davis C; Aronson N; Ruiz N; Birx DL; Michael NL
    J Infect Dis; 1998 Dec; 178(6):1799-802. PubMed ID: 9815238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly and intracellular trafficking of HLA-B*3501 and HLA-B*3503.
    Thammavongsa V; Schaefer M; Filzen T; Collins KL; Carrington M; Bangia N; Raghavan M
    Immunogenetics; 2009 Dec; 61(11-12):703-16. PubMed ID: 19838694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 (HIV-1)-specific CD8+-T-cell responses for groups of HIV-1-infected individuals with different HLA-B*35 genotypes.
    Jin X; Gao X; Ramanathan M; Deschenes GR; Nelson GW; O'Brien SJ; Goedert JJ; Ho DD; O'Brien TR; Carrington M
    J Virol; 2002 Dec; 76(24):12603-10. PubMed ID: 12438586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
    ; Pereyra F; Jia X; McLaren PJ; Telenti A; de Bakker PI; Walker BD; Ripke S; Brumme CJ; Pulit SL; Carrington M; Kadie CM; Carlson JM; Heckerman D; Graham RR; Plenge RM; Deeks SG; Gianniny L; Crawford G; Sullivan J; Gonzalez E; Davies L; Camargo A; Moore JM; Beattie N; Gupta S; Crenshaw A; Burtt NP; Guiducci C; Gupta N; Gao X; Qi Y; Yuki Y; Piechocka-Trocha A; Cutrell E; Rosenberg R; Moss KL; Lemay P; O'Leary J; Schaefer T; Verma P; Toth I; Block B; Baker B; Rothchild A; Lian J; Proudfoot J; Alvino DM; Vine S; Addo MM; Allen TM; Altfeld M; Henn MR; Le Gall S; Streeck H; Haas DW; Kuritzkes DR; Robbins GK; Shafer RW; Gulick RM; Shikuma CM; Haubrich R; Riddler S; Sax PE; Daar ES; Ribaudo HJ; Agan B; Agarwal S; Ahern RL; Allen BL; Altidor S; Altschuler EL; Ambardar S; Anastos K; Anderson B; Anderson V; Andrady U; Antoniskis D; Bangsberg D; Barbaro D; Barrie W; Bartczak J; Barton S; Basden P; Basgoz N; Bazner S; Bellos NC; Benson AM; Berger J; Bernard NF; Bernard AM; Birch C; Bodner SJ; Bolan RK; Boudreaux ET; Bradley M; Braun JF; Brndjar JE; Brown SJ; Brown K; Brown ST; Burack J; Bush LM; Cafaro V; Campbell O; Campbell J; Carlson RH; Carmichael JK; Casey KK; Cavacuiti C; Celestin G; Chambers ST; Chez N; Chirch LM; Cimoch PJ; Cohen D; Cohn LE; Conway B; Cooper DA; Cornelson B; Cox DT; Cristofano MV; Cuchural G; Czartoski JL; Dahman JM; Daly JS; Davis BT; Davis K; Davod SM; DeJesus E; Dietz CA; Dunham E; Dunn ME; Ellerin TB; Eron JJ; Fangman JJ; Farel CE; Ferlazzo H; Fidler S; Fleenor-Ford A; Frankel R; Freedberg KA; French NK; Fuchs JD; Fuller JD; Gaberman J; Gallant JE; Gandhi RT; Garcia E; Garmon D; Gathe JC; Gaultier CR; Gebre W; Gilman FD; Gilson I; Goepfert PA; Gottlieb MS; Goulston C; Groger RK; Gurley TD; Haber S; Hardwicke R; Hardy WD; Harrigan PR; Hawkins TN; Heath S; Hecht FM; Henry WK; Hladek M; Hoffman RP; Horton JM; Hsu RK; Huhn GD; Hunt P; Hupert MJ; Illeman ML; Jaeger H; Jellinger RM; John M; Johnson JA; Johnson KL; Johnson H; Johnson K; Joly J; Jordan WC; Kauffman CA; Khanlou H; Killian RK; Kim AY; Kim DD; Kinder CA; Kirchner JT; Kogelman L; Kojic EM; Korthuis PT; Kurisu W; Kwon DS; LaMar M; Lampiris H; Lanzafame M; Lederman MM; Lee DM; Lee JM; Lee MJ; Lee ET; Lemoine J; Levy JA; Llibre JM; Liguori MA; Little SJ; Liu AY; Lopez AJ; Loutfy MR; Loy D; Mohammed DY; Man A; Mansour MK; Marconi VC; Markowitz M; Marques R; Martin JN; Martin HL; Mayer KH; McElrath MJ; McGhee TA; McGovern BH; McGowan K; McIntyre D; Mcleod GX; Menezes P; Mesa G; Metroka CE; Meyer-Olson D; Miller AO; Montgomery K; Mounzer KC; Nagami EH; Nagin I; Nahass RG; Nelson MO; Nielsen C; Norene DL; O'Connor DH; Ojikutu BO; Okulicz J; Oladehin OO; Oldfield EC; Olender SA; Ostrowski M; Owen WF; Pae E; Parsonnet J; Pavlatos AM; Perlmutter AM; Pierce MN; Pincus JM; Pisani L; Price LJ; Proia L; Prokesch RC; Pujet HC; Ramgopal M; Rathod A; Rausch M; Ravishankar J; Rhame FS; Richards CS; Richman DD; Rodes B; Rodriguez M; Rose RC; Rosenberg ES; Rosenthal D; Ross PE; Rubin DS; Rumbaugh E; Saenz L; Salvaggio MR; Sanchez WC; Sanjana VM; Santiago S; Schmidt W; Schuitemaker H; Sestak PM; Shalit P; Shay W; Shirvani VN; Silebi VI; Sizemore JM; Skolnik PR; Sokol-Anderson M; Sosman JM; Stabile P; Stapleton JT; Starrett S; Stein F; Stellbrink HJ; Sterman FL; Stone VE; Stone DR; Tambussi G; Taplitz RA; Tedaldi EM; Telenti A; Theisen W; Torres R; Tosiello L; Tremblay C; Tribble MA; Trinh PD; Tsao A; Ueda P; Vaccaro A; Valadas E; Vanig TJ; Vecino I; Vega VM; Veikley W; Wade BH; Walworth C; Wanidworanun C; Ward DJ; Warner DA; Weber RD; Webster D; Weis S; Wheeler DA; White DJ; Wilkins E; Winston A; Wlodaver CG; van't Wout A; Wright DP; Yang OO; Yurdin DL; Zabukovic BW; Zachary KC; Zeeman B; Zhao M
    Science; 2010 Dec; 330(6010):1551-7. PubMed ID: 21051598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-B35 is associated with accelerated progression to AIDS.
    Itescu S; Mathur-Wagh U; Skovron ML; Brancato LJ; Marmor M; Zeleniuch-Jacquotte A; Winchester R
    J Acquir Immune Defic Syndr (1988); 1992; 5(1):37-45. PubMed ID: 1738086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.
    Altfeld M; Kalife ET; Qi Y; Streeck H; Lichterfeld M; Johnston MN; Burgett N; Swartz ME; Yang A; Alter G; Yu XG; Meier A; Rockstroh JK; Allen TM; Jessen H; Rosenberg ES; Carrington M; Walker BD
    PLoS Med; 2006 Oct; 3(10):e403. PubMed ID: 17076553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grouping HLA-B locus serologic specificities according to shared structural motifs suggests that different peptide-anchoring pockets may have contrasting influences on the course of HIV-1 infection.
    Itescu S; Rose S; Dwyer E; Winchester R
    Hum Immunol; 1995 Jan; 42(1):81-9. PubMed ID: 7751163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses.
    Huang J; Goedert JJ; Sundberg EJ; Cung TD; Burke PS; Martin MP; Preiss L; Lifson J; Lichterfeld M; Carrington M; Yu XG
    J Exp Med; 2009 Dec; 206(13):2959-66. PubMed ID: 20008523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of HLA-B*35 subtype differences on HIV disease outcome in Mexico.
    Juarez-Molina CI; Valenzuela-Ponce H; Avila-Rios S; Garrido-Rodriguez D; Garcia-Tellez T; Soto-Nava M; Garcia-Morales C; Goulder P; Reyes-Teran G
    AIDS; 2014 Jul; 28(11):1687-90. PubMed ID: 24853499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HLA A03 Supertype and Several
    de Groot NG; Heijmans CMC; de Ru AH; Otting N; Koning F; van Veelen PA; Bontrop RE
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1-specific cytotoxic T lymphocyte (CTL) responses against immunodominant optimal epitopes slow the progression of AIDS in China.
    Zhai S; Zhuang Y; Song Y; Li S; Huang D; Kang W; Li X; Liao Q; Liu Y; Zhao Z; Lu Y; Sun Y
    Curr HIV Res; 2008 Jun; 6(4):335-50. PubMed ID: 18691032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1.
    Tang J; Tang S; Lobashevsky E; Myracle AD; Fideli U; Aldrovandi G; Allen S; Musonda R; Kaslow RA;
    J Virol; 2002 Aug; 76(16):8276-84. PubMed ID: 12134033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Micropolymorphism Outside the Peptide Binding Groove in the Clinically Relevant Allele HLA-C*14 on T Cell Responses in HIV-1 Infection.
    Chikata T; Paes W; Kuse N; Partridge T; Gatanaga H; Zhang Y; Kuroki K; Maenaka K; Ternette N; Oka S; Borrow P; Takiguchi M
    J Virol; 2022 May; 96(10):e0043222. PubMed ID: 35475667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.